Molecular risk assessment

From Wikipedia, the free encyclopedia

Molecular risk assessment is a procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person’s risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.

[edit] External links

• Molecular risk assessment entry in the public domain NCI Dictionary of Cancer Terms

This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms